Roberto I.
- Country
- Italy
- Department
- Oncologia Medica
Research Overview
- "APalutamide and stEReotactic body radiation therapy for low burden metastatic hormone senSItive prostate cancer, a rANdomized trial -PERSIAN".
- A Phase 3 Study of MK-2870 Versus Investigator’s Choice of Non-platinum Chemotherapy in Participants with Pretreated Locally Advanced or Metastatic Urothelial Carcinoma
- Phase 3 Study of Vepugratinib and Combination Therapy in Adults with Untreated FGFR3-Altered Locally Advanced or Metastatic Urothelial Carcinoma
Data & Insights
Has run more than one trial at 279 of 516 partner sites.
Specializations
Urological Oncology
The investigator specializes in treating advanced urothelial carcinoma and bladder cancer, with particular emphasis on HER2-expressing tumors and muscle-invasive disease. Their research encompasses both early-stage and metastatic disease management.
- Urothelial Cancer Therapeutics
- Muscle-Invasive Bladder Cancer
- Novel Combination Approaches
Renal Cancer Research
Focuses on advancing treatment options for renal cell carcinoma, including clear cell and non-clear cell variants. The investigator explores various therapeutic approaches for both localized and metastatic disease states.
- Advanced RCC Treatment
- Immunotherapy Applications
- Targeted Therapy Combinations
Prostate Cancer Studies
Conducts research in metastatic prostate cancer treatment, including both hormone-sensitive and castration-resistant disease states. Their work encompasses novel therapeutic approaches and combination strategies.
- Castration-Resistant Disease
- Hormone-Sensitive Disease
- Novel Therapeutic Combinations
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.